HealthWarehouse.com Inc. Reports 182% Increase in Q2 Sales and $228,000 Net Income
Reuters
Aug 13
HealthWarehouse.com Inc. Reports 182% Increase in <a href="https://laohu8.com/S/QTWO">Q2</a> Sales and $228,000 Net Income
HealthWarehouse.com Inc. reported robust financial results for the second quarter of 2025, showcasing a significant 182% increase in net sales, which totaled $15.7 million. This surge was primarily driven by a 495% growth in partner services revenues. The company recorded a net income of $228,000 for the quarter, a notable turnaround from a net loss of $344,000 in the same period the previous year. HealthWarehouse.com also reported an Adjusted EBITDA of $568,000, which marks a substantial improvement compared to the $25,000 reported for the second quarter of 2024. HealthWarehouse.com operates as a technology company focusing on healthcare e-commerce, providing prescription and over-the-counter medications across all 50 states as an Approved Digital Pharmacy through the National Association of Boards of Pharmacy (NABP). The company emphasizes its commitment to enhancing accessibility and reducing costs of healthcare products for consumers and business partners nationwide. No future financial guidance or outlook was provided in the report.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthWarehouse.com Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250812889524) on August 12, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.